156 related articles for article (PubMed ID: 23443669)
1. Pneumocystis pneumonia during primary HIV infection: a case report and review of the literature.
Ungprasert P; Permpalung N; Srivali N; Bischof EF; Edmonds LC
J Infect Chemother; 2013 Oct; 19(5):990-1. PubMed ID: 23443669
[TBL] [Abstract][Full Text] [Related]
2. Severe and long lasting cholestasis after high-dose co-trimoxazole treatment for Pneumocystis pneumonia in HIV-infected patients--a report of two cases.
Hanses F; Zierhut S; Schölmerich J; Salzberger B; Wrede CE
Int J Infect Dis; 2009 Nov; 13(6):e467-9. PubMed ID: 19299179
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary nocardiosis caused by Nocardia exalbida complicating Pneumocystis pneumonia in an HIV-infected patient.
Imai K; Koibuchi T; Kikuchi T; Koga M; Nakamura H; Miura T; Gonoi T; Yazawa K; Iwamoto A; Fujii T
J Infect Chemother; 2011 Aug; 17(4):547-51. PubMed ID: 21249414
[TBL] [Abstract][Full Text] [Related]
4. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.
Thomas M; Rupali P; Woodhouse A; Ellis-Pegler R
Scand J Infect Dis; 2009; 41(11-12):862-8. PubMed ID: 19922070
[TBL] [Abstract][Full Text] [Related]
5. Outcome from treatment of Pneumocystis jirovecii pneumonia with co-trimoxazole.
Fisk M; Sage EK; Edwards SG; Cartledge JD; Miller RF
Int J STD AIDS; 2009 Sep; 20(9):652-3. PubMed ID: 19710343
[TBL] [Abstract][Full Text] [Related]
6. Unusual case of Pneumocystis jiroveci pneumonia during primary HIV infection.
Byers DK; Decker CF
AIDS Read; 2008 Jun; 18(6):313-7. PubMed ID: 18623893
[TBL] [Abstract][Full Text] [Related]
7. Pneumocystis and Pneumocystosis: first meeting of experts from Latin-American and Portuguese-speaking countries - a mini-review.
Esteves F; Medrano FJ; de Armas Y; Wissmann G; Calderón EJ; Matos O
Expert Rev Anti Infect Ther; 2014 May; 12(5):545-8. PubMed ID: 24617414
[TBL] [Abstract][Full Text] [Related]
8. A case of pneumocystis pneumonia after cessation of secondary prophylaxis.
Quah SP; McBride M
Int J STD AIDS; 2001 Feb; 12(2):126-7. PubMed ID: 11236102
[TBL] [Abstract][Full Text] [Related]
9. Pneumocystis jirovecii Pneumonia in Human Immunodeficiency Virus Infection.
Siegel M; Masur H; Kovacs J
Semin Respir Crit Care Med; 2016 Apr; 37(2):243-56. PubMed ID: 26974301
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic failure of trimethoprim/sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia.
al-Tawfiq JA; Sorensen SJ; Cushing HE
Ann Pharmacother; 1999 Apr; 33(4):413-5. PubMed ID: 10332530
[TBL] [Abstract][Full Text] [Related]
11. Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
Antinori A; Murri R; Ammassari A
AIDS; 1996 Aug; 10(9):1046-7. PubMed ID: 8853743
[No Abstract] [Full Text] [Related]
12. Current management practices in the treatment of Pneumocystis carinii pneumonia (PCP).
Blanchet KD
AIDS Patient Care STDS; 1996 Apr; 10(2):116-21. PubMed ID: 11361688
[No Abstract] [Full Text] [Related]
13. [Pneumocystis pneumonia in a renal transplant recipient].
Özkoç S; İnceboz T; Sıfıl A; Tuncay S; Akisü Ç
Turkiye Parazitol Derg; 2010; 34(4):186-9. PubMed ID: 21391190
[TBL] [Abstract][Full Text] [Related]
14. Why does Pneumocystis carinii pneumonia still occur?
Huang L; Hecht FM
AIDS; 2000 Nov; 14(16):2611-2. PubMed ID: 11101076
[No Abstract] [Full Text] [Related]
15. Prevalence of dihydropteroate synthase genotypes before and after the introduction of combined antiretroviral therapy and their influence on the outcome of Pneumocystis pneumonia in HIV-1-infected patients.
Alvarez-Martínez MJ; Miró JM; Valls ME; Mas J; de la Bellacasa JP; Sued O; Solé M; Rivas PV; de Lazzari E; Benito N; García F; Agustí C; Wilson PE; Gatell JM; Jiménez de Anta MT; Meshnick SR; Moreno A
Diagn Microbiol Infect Dis; 2010 Sep; 68(1):60-5. PubMed ID: 20727472
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.
Markantonatou AM; Ioakimidou A; Arvaniti K; Manou E; Papadopoulos V; Kiriklidou P; Samaras K; Kioumi A; Vyzantiadis TA
Mycoses; 2017 Oct; 60(10):626-633. PubMed ID: 28660636
[TBL] [Abstract][Full Text] [Related]
17. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy.
Mammen-Tobin A; Monteiro EF
Int J STD AIDS; 2000 Jan; 11(1):64-5. PubMed ID: 10667904
[No Abstract] [Full Text] [Related]
19. Central retinal vein occlusion in an AIDS patient with presumed Pneumocystis carinii pneumonia.
Yeh S; Lam HY; Albini TA; Holz ER
Can J Ophthalmol; 2008 Jun; 43(3):372-3. PubMed ID: 18443615
[No Abstract] [Full Text] [Related]
20. Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
Smith CL; Brown I; Torraca BM
Clin Infect Dis; 1997 Dec; 25(6):1477-8. PubMed ID: 9431404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
